Skip to main content

Professional Activities

Conference Roles

  • Immune mediators in DILI: Lessons to be learned from studies with human cells. , by Invitation (Joint MDO/ISSX Meeting Amsterdam, 2011)
  • Should the hapten hypothesis be used in 2011 to define the chemical basis of immune-mediated ...., by Invitation (Gordon Conference on Drug Metabolism, New Hampshire, USA., 2011)
  • Development of in vitro T-cell methods to predict the sensitizing potential of drugs, by Invitation (SENSITIV meeting, Brussels, Belgium, 2011)
  • The role of the adaptive immune system in drug-induced liver injury, by Invitation (The Liver Meeting, San Francisco, USA, 2011)
  • Novel Challenges in Cystic Fibrosis Infection , by Invitation (European Cystic Fibrosis Society, Valencia, Spain, 2011)
  • The chemical reactivity, antigenicity and immunogenicity of p-phenylenediamine. , by Invitation (10th Congress of the ESCD, Strasburg, France, 2010)
  • The Chemical and Cellular basis of drug hypersensitivity., by Invitation (St Thomas’s Hospital, London, UK., 2009)
  • The role of the immune system in adverse drug reactions. , by Invitation (ESF-UB Conference Pharmacogenetics and Pharmacogenomics, Barcelona, Spain, 2009)
  • The role of metabolism in immune-mediated allergic reactions, by Invitation (AAAAI Annual Meeting, Washington DC, USA., 2009)
  • e role of metabolism in T-cell mediated drug hypersensitivity reactions, by Invitation (46th Congress of the European Societies of Toxicology, 2009)
  • The ISSX European New Investigator Award & the ESBP Founders Lecture in Honour of Karl Netter,, by Invitation (European ISSX meeting, Lisbon, Portugal, 2009)
  • Drug Allergy, clinical and fundamental aspects. , by Invitation (Surrey, UK, 2009)
  • The Chemical basis of drug-induced allergic reactions. , by Invitation (International Conference on Dermatotoxicology, Aachen, Germany, 2009)
  • The role of T-cells in drug-induced allergic reactions. , by Invitation (Leeds Universtiry , 2009)
  • Basic mechanisms of drug hypersensitivity, by Invitation (4th International Drug Hypersensitivity Meeting, 2009)
  • Drug metabolism and allergy, by Invitation (Conference: New Trends in Paediatric Asthma and Allergy, London, UK, 2009)
  • BSTP Education Module on the Lymphoid/Haemopoietic System, by Invitation (Cambridge University, 2007)
  • Dendritic cell signaling and drug hypersensitivity, by Invitation (ERGECD meeting, 2007)
  • Chemical and cellular mechanisms of drug hypersensitivity, by Invitation (University of Western Ontario, Canada, 2007)
  • Role of Metabolism in Drug Hypersensitivity, by Invitation (Aachen, Germany, 2007)
  • Chemical Mechanisms of Allergic Contact Dermatitis, by Invitation (University of London, 2007)
  • Mechanisms of Drug Hypersensitivity, by Invitation (North East Immunology Society, 2007)
  • Drug Allergy, clinical and fundamental aspects. , by Invitation (The University of Surrey, 2007)
  • Lecturer, International symposium of adverse drug reactions, Yokohama, Japan, by Invitation (Japanese Society of Allergy and Immunology, 2006)
  • 2nd Drug hypersensitivity meeting, Liverpool, UK, by Invitation (The University of Liverpool, 2006)
  • ITCASS meeting, Manchester, UK, by Invitation (ITCASS society, 2005)
  • 3 lectures to be arranged at industrial or academic venues in the UK. A condition of the Bill Bowman, by Invitation (bish Pharmacological Society, 2005)

Editorships

  • Chemical Research in Toxicology (Editorial Board Member, 2009 - present)
  • The Open Allergy Journal (Advisory Editorial Board Member, 2007 - present)
  • Immunology (Advisory Editorial Board Member, 2006 - present)

Examination Roles

  • Southampton University, PhD (2011)
  • University of Southampton, PhD (2011)

Professional Body Memberships

  • British Pharmacological Society (Fellow, 2012 - present)
  • International Society for the Study of Xenobiotics (Member, 2011 - present)
  • European Academy of Allergology and Clinical Immunology (Member, 2003 - present)
  • British Toxicological Society (Member, 1998 - present)